Reuters Science News Summary

Reuters Science News Summary

Following is a summary of current science news briefs.

Does drug touted by Trump work on COVID-19? After data debacle, we still don't know

Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential "game-changer" in fighting the pandemic. The renewed research push follows widespread criticism of the quality of data in a study that on Thursday was retracted. The article, originally published in influential medical journal The Lancet, had found high risks associated with the treatment.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.